FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for treating cachexia and brain-related diseases. Researchers at Oregon State Un ...